Pharmaceutical industry: Free speech rights run up against limits on product claims

Merck agreed to pay $950 million to settle a suit over its claims for the painkiller Vioxx withdrawn from sales for increasing the chance of heart attack.

But companies are aggressively challenging the government in its attempts to held industries accountable for the truthfulness of their promotions. -db

From the Philadelphia Inquirer, November 27, 2011, by David Sel.

Full story